MAM
Binay Tiwari forays into entrepreneurship
MUMBAI: Vserv.mobi director – global marketing & product Binay Tiwari has decided to wear the hat of an entrepreneur and has thus resigned from his current role.
Tiwari through a statement said, “Over the past three years I’ve had an amazing time working with Vserv and its partners across the world, to push forward the mobile internet ecosystem. Today, I stand at a juncture, where I’m keen to take a new path towards ‘starting up’ something new of my own. We are living in exciting times, where technology is changing the world at an unprecedented pace, and I hope to leverage the massive opportunities that this presents.”
Tiwari had joined Vserv in August 2011 as its general manager. He was later promoted as the global marketing head in March 2012 and as the director of global marketing and product in April last year. Tiwari had previously worked in companies like InMobi, Vodafone, Tata Communications, GE Capital International Services and Mukunda Gems.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
